Evidence map›Paper›PMID 42046256›Full record

ArticleRheumatology (Oxford, England)2026

Single-cell profiling reveals CCL5Hi GZMAHi effector memory CD8 T cell association to oligoarticular JIA.

Mireia Lopez-Corbeto, Yolanda Guillén, Laura Jiménez-Gracia, Estefanía Moreno-Ruzafa, Damiana Alvarez-Errico, Núria Palau, Nieves Martín-Begué, Holger Heyn, Antonio Julià, Sara Marsal

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Mireia Lopez-CorbetoPaediatric Rheumatology Unit, Rheumatology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Yolanda GuillénIMIDomics, Inc, Barcelona, Spain.
Laura Jiménez-GraciaCentro Nacional de Análisis Genómico, Barcelona, Spain.
Estefanía Moreno-RuzafaPaediatric Rheumatology Unit, Rheumatology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Damiana Alvarez-ErricoIMIDomics, Inc, Barcelona, Spain.
Núria PalauRheumatology Research Group, Rheumatology Department, Vall Hebron Barcelona Hospital Campus, Barcelona, Spain.
Nieves Martín-BeguéPaediatric Ophtalmology Unit, Ophtalmology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Holger HeynCentro Nacional de Análisis Genómico, Barcelona, Spain.ORCID 0000-0002-3276-1889
Antonio JuliàRheumatology Research Group, Rheumatology Department, Vall Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0001-6064-3620
Sara MarsalRheumatology Research Group, Rheumatology Department, Vall Hebron Barcelona Hospital Campus, Barcelona, Spain.

Funding

FPU PhD fellowship FPU19/04886Instituto Carlos III PI19/00225Ministry of UniversitiesMoving4 in Juvenile Idiopathic Arthritis 2022 research grant from the Spanish Society of Pediatric Rheumatology
6 · The paper itself

Abstract

objectivesOligoarticular JIA (oligo JIA) is the most common JIA subtype and is often complicated by uveitis, a potentially sight-threatening comorbidity. Despite its prevalence, the immunopathogenic mechanisms underlying oligo JIA and its extra-articular manifestations remain poorly understood. The objective was to characterize the immune landscape of oligo JIA and identify pathogenic cell populations and regulatory mechanisms associated with the disease and uveitis.

methodsSingle-cell RNA and TCR sequencing (scRNA/TCR-Seq) was performed on peripheral blood mononuclear cells (PBMCs) and paired SF from three treatment-naïve, new-onset oligo JIA patients, on PBMC from four oligo JIA patients with uveitis flare and from four age-matched healthy controls (HCs) (discovery cohort; n = 14 samples). Cellular composition, gene expression and T cell clonality were analysed. Key findings were validated by mass cytometry (CyTOF) in an independent cohort of 13 oligo JIA patients, eight uveitis flare patients and six HCs.

resultsscRNA-seq of 132 824 immune cells revealed enrichment of activated effector memory CD8+ T cells (CD8+TEM), intermediate monocytes and regulatory T cells in SF. CD8+TEM were depleted in blood, suggesting a recruitment from the circulation into the inflamed joint. SF CD8+TEM displayed upregulation of CCL5, GZMA and GNLY and showed marked clonal expansion. In patients with uveitis, MAIT cells were clonally expanded and transcriptionally reprogrammed with IFN-stimulated and cytotoxic signatures. CyTOF confirmed reduced circulating CCL5Hi GZMAHi CD8+TEM in oligo JIA.

conclusionsClonally expanded, cytotoxic CD8+ TEM cells drive joint inflammation in oligo JIA, while activated MAIT and NK cells in uveitis indicate systemic immune activation and potential therapeutic targets.

Indexed as

Arthritis, JuvenileCD8-Positive T-LymphocytesChemokine CCL5Memory T CellsAdolescentChildFemaleHumansImmunologic MemoryMaleSingle-Cell AnalysisUveitisCCL5 protein, humanChemokine CCL5JIAsingle-cell RNA sequencingTCR sequencinguveitis

Identifiers

PMID42046256
PMCPMC13278834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.